PMC:7243778 / 29685-30465 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"746","span":{"begin":474,"end":477},"obj":"Gene"},{"id":"747","span":{"begin":459,"end":464},"obj":"Gene"},{"id":"748","span":{"begin":444,"end":449},"obj":"Gene"},{"id":"749","span":{"begin":127,"end":132},"obj":"Species"},{"id":"750","span":{"begin":133,"end":146},"obj":"Species"},{"id":"751","span":{"begin":188,"end":198},"obj":"Species"},{"id":"752","span":{"begin":200,"end":208},"obj":"Species"},{"id":"753","span":{"begin":214,"end":222},"obj":"Species"},{"id":"754","span":{"begin":262,"end":272},"obj":"Species"},{"id":"755","span":{"begin":285,"end":302},"obj":"Species"},{"id":"756","span":{"begin":312,"end":321},"obj":"Species"},{"id":"757","span":{"begin":326,"end":335},"obj":"Species"},{"id":"758","span":{"begin":373,"end":383},"obj":"Species"},{"id":"759","span":{"begin":544,"end":552},"obj":"Species"},{"id":"760","span":{"begin":524,"end":543},"obj":"Disease"},{"id":"761","span":{"begin":753,"end":773},"obj":"Disease"}],"attributes":[{"id":"A746","pred":"tao:has_database_id","subj":"746","obj":"Gene:920"},{"id":"A747","pred":"tao:has_database_id","subj":"747","obj":"Gene:43740568"},{"id":"A748","pred":"tao:has_database_id","subj":"748","obj":"Gene:43740568"},{"id":"A749","pred":"tao:has_database_id","subj":"749","obj":"Tax:9606"},{"id":"A750","pred":"tao:has_database_id","subj":"750","obj":"Tax:11118"},{"id":"A751","pred":"tao:has_database_id","subj":"751","obj":"Tax:2697049"},{"id":"A752","pred":"tao:has_database_id","subj":"752","obj":"Tax:694009"},{"id":"A753","pred":"tao:has_database_id","subj":"753","obj":"Tax:1335626"},{"id":"A754","pred":"tao:has_database_id","subj":"754","obj":"Tax:2697049"},{"id":"A755","pred":"tao:has_database_id","subj":"755","obj":"Tax:694002"},{"id":"A756","pred":"tao:has_database_id","subj":"756","obj":"Tax:31631"},{"id":"A757","pred":"tao:has_database_id","subj":"757","obj":"Tax:290028"},{"id":"A758","pred":"tao:has_database_id","subj":"758","obj":"Tax:2697049"},{"id":"A759","pred":"tao:has_database_id","subj":"759","obj":"Tax:9606"},{"id":"A760","pred":"tao:has_database_id","subj":"760","obj":"MESH:C000657245"},{"id":"A761","pred":"tao:has_database_id","subj":"761","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In a serologic cross-reactivity test, Khan et al. found out that 4 out of 5 showed high IgG seroreactivity across the 4 common human coronaviruses but all showed low IgG seroreactivity to SARS-CoV-2, SARS-CoV, and MERS-CoV [102]. The weak cross-immunity against SARS-CoV-2 from others betacoronaviruses, such as HCoV-OC43 and HCoV-HKU1, could restraint the transmission of SARS-CoV-2 but a resurgence is possible in the future [103]. Moreover, spike- and non-spike specific CD4+ T cell responses were detectable not only in SARS-CoV-2 infected patients but also in uninfected individuals. If there is an absence of antibody cross-reactivity, T lymphocyte cross-reactivity present in 50% of cases will be responsible for the epidemiological evolution of SARS-CoV-2 infection [104]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T138","span":{"begin":88,"end":91},"obj":"Body_part"},{"id":"T139","span":{"begin":166,"end":169},"obj":"Body_part"},{"id":"T140","span":{"begin":481,"end":485},"obj":"Body_part"},{"id":"T141","span":{"begin":615,"end":623},"obj":"Body_part"},{"id":"T142","span":{"begin":642,"end":654},"obj":"Body_part"}],"attributes":[{"id":"A138","pred":"fma_id","subj":"T138","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A139","pred":"fma_id","subj":"T139","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A140","pred":"fma_id","subj":"T140","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A141","pred":"fma_id","subj":"T141","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A142","pred":"fma_id","subj":"T142","obj":"http://purl.org/sig/ont/fma/fma62870"}],"text":"In a serologic cross-reactivity test, Khan et al. found out that 4 out of 5 showed high IgG seroreactivity across the 4 common human coronaviruses but all showed low IgG seroreactivity to SARS-CoV-2, SARS-CoV, and MERS-CoV [102]. The weak cross-immunity against SARS-CoV-2 from others betacoronaviruses, such as HCoV-OC43 and HCoV-HKU1, could restraint the transmission of SARS-CoV-2 but a resurgence is possible in the future [103]. Moreover, spike- and non-spike specific CD4+ T cell responses were detectable not only in SARS-CoV-2 infected patients but also in uninfected individuals. If there is an absence of antibody cross-reactivity, T lymphocyte cross-reactivity present in 50% of cases will be responsible for the epidemiological evolution of SARS-CoV-2 infection [104]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T140","span":{"begin":188,"end":196},"obj":"Disease"},{"id":"T141","span":{"begin":200,"end":208},"obj":"Disease"},{"id":"T142","span":{"begin":262,"end":270},"obj":"Disease"},{"id":"T143","span":{"begin":373,"end":381},"obj":"Disease"},{"id":"T144","span":{"begin":524,"end":532},"obj":"Disease"},{"id":"T145","span":{"begin":753,"end":761},"obj":"Disease"},{"id":"T146","span":{"begin":764,"end":773},"obj":"Disease"}],"attributes":[{"id":"A140","pred":"mondo_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A143","pred":"mondo_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A144","pred":"mondo_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A145","pred":"mondo_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"In a serologic cross-reactivity test, Khan et al. found out that 4 out of 5 showed high IgG seroreactivity across the 4 common human coronaviruses but all showed low IgG seroreactivity to SARS-CoV-2, SARS-CoV, and MERS-CoV [102]. The weak cross-immunity against SARS-CoV-2 from others betacoronaviruses, such as HCoV-OC43 and HCoV-HKU1, could restraint the transmission of SARS-CoV-2 but a resurgence is possible in the future [103]. Moreover, spike- and non-spike specific CD4+ T cell responses were detectable not only in SARS-CoV-2 infected patients but also in uninfected individuals. If there is an absence of antibody cross-reactivity, T lymphocyte cross-reactivity present in 50% of cases will be responsible for the epidemiological evolution of SARS-CoV-2 infection [104]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T355","span":{"begin":3,"end":4},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T356","span":{"begin":32,"end":36},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T357","span":{"begin":127,"end":132},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T358","span":{"begin":224,"end":227},"obj":"http://purl.obolibrary.org/obo/CLO_0054060"},{"id":"T359","span":{"begin":388,"end":389},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T360","span":{"begin":474,"end":477},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T361","span":{"begin":479,"end":485},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"In a serologic cross-reactivity test, Khan et al. found out that 4 out of 5 showed high IgG seroreactivity across the 4 common human coronaviruses but all showed low IgG seroreactivity to SARS-CoV-2, SARS-CoV, and MERS-CoV [102]. The weak cross-immunity against SARS-CoV-2 from others betacoronaviruses, such as HCoV-OC43 and HCoV-HKU1, could restraint the transmission of SARS-CoV-2 but a resurgence is possible in the future [103]. Moreover, spike- and non-spike specific CD4+ T cell responses were detectable not only in SARS-CoV-2 infected patients but also in uninfected individuals. If there is an absence of antibody cross-reactivity, T lymphocyte cross-reactivity present in 50% of cases will be responsible for the epidemiological evolution of SARS-CoV-2 infection [104]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T232","span":{"begin":0,"end":229},"obj":"Sentence"},{"id":"T233","span":{"begin":230,"end":433},"obj":"Sentence"},{"id":"T234","span":{"begin":434,"end":588},"obj":"Sentence"},{"id":"T235","span":{"begin":589,"end":780},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In a serologic cross-reactivity test, Khan et al. found out that 4 out of 5 showed high IgG seroreactivity across the 4 common human coronaviruses but all showed low IgG seroreactivity to SARS-CoV-2, SARS-CoV, and MERS-CoV [102]. The weak cross-immunity against SARS-CoV-2 from others betacoronaviruses, such as HCoV-OC43 and HCoV-HKU1, could restraint the transmission of SARS-CoV-2 but a resurgence is possible in the future [103]. Moreover, spike- and non-spike specific CD4+ T cell responses were detectable not only in SARS-CoV-2 infected patients but also in uninfected individuals. If there is an absence of antibody cross-reactivity, T lymphocyte cross-reactivity present in 50% of cases will be responsible for the epidemiological evolution of SARS-CoV-2 infection [104]."}